The number of people with susceptibility test result for rifampicin in Malaysia
Malaysia: The number of people with susceptibility test result for rifampicin was 84.34 in 2021. ▲ Rising
Latest (2021)
84.34
Change on year
up 8.2%
World rank
86th
of 146 countries
All-time high
84.34
in 2021
All-time low
76.18
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Malaysia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Malaysia is 84.34, measured in 2021. That is the highest value across all 5 years on record.
The figure is up 8.2% on the previous year and up 10.7% over five years.
Malaysia ranks 86th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Malaysia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 76.18 | — |
| 2018 | 77.84 | +2.2% |
| 2019 | 80.12 | +2.9% |
| 2020 | 77.96 | -2.7% |
| 2021 | 84.34 | +8.2% |
Malaysia compared with similar countries
- Malaysia's 84.34 is below the median for upper middle income countries, which is 92.7, 91% of the median. (45 countries reporting)
- Malaysia's 84.34 is below the median for East Asia & Pacific, which is 96.47, 87% of the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 78.05 | 76.18 | 80.12 | 3 |
| 2020s | 81.15 | 77.96 | 84.34 | 2 |
Countries ranked near Malaysia
More health data for Malaysia
- Un projection of annual infant deaths, annual growth rate -0.9119 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2888 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,250 deaths per 1,000 people (2090)
- Number of infants who die before age 1 652 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 18 (2025)
- Population ages 00-04, female, annual growth rate -0.7207 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0297 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5991 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Malaysia?
- The number of people with susceptibility test result for rifampicin in Malaysia was 84.34 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Malaysia?
- The highest recorded value was 84.34 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Malaysia?
- The lowest recorded value was 76.18 in 2017.
- How does Malaysia rank for the number of people with susceptibility test result for rifampicin?
- Malaysia ranks 86th out of 146 countries with data for 2021.
- Where does this Malaysia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).